drugset / Trial / NCT06782594
A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled phase II clinical study.
Timeline
- Start
- 2024-10-18
- Primary completion
- 2025-06
- Completion
- 2025-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mosapride | Small molecule | 4 mg | Intravenous |
| Subject | Mosapride | Small molecule | 8 mg | Intravenous |